Ascend Wellness Holdings (AAWH) Change in Receivables (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Change in Receivables of -$601000.0 in Q1 2026, up 67.01% quarter-over-quarter from -$1.8 million in Q4 2025, and down 437.64% on a YoY basis from $178000.0 in Q1 2025.
Ascend Wellness Holdings (AAWH) Change in Receivables (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Change in Receivables history runs 7 years deep, the most recent figure standing at -$601000.0 for Q1 2026.
- In Q1 2026, Change in Receivables fell 437.64% year-over-year to -$601000.0; the TTM figure through Mar 2026 stood at -$8.7 million (down 1158.27% YoY), while the FY2025 annual figure was -$7.9 million, down 196.07% from the prior year.
- Change in Receivables was -$601000.0 for Q1 2026 at Ascend Wellness Holdings, up from -$1.8 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $7.6 million in Q1 2024 to a low of -$6.1 million in Q2 2025.
- Historically, Change in Receivables has averaged $1.2 million across 5 years, with a median of $714000.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Change in Receivables surged 320.5% in 2023, then tumbled 940.17% in 2025.
- A 5-year view of Change in Receivables shows it stood at $714000.0 in 2022, then jumped by 308.82% to $2.9 million in 2023, then sank by 176.5% to -$2.2 million in 2024, then increased by 18.41% to -$1.8 million in 2025, then soared by 67.01% to -$601000.0 in 2026.
- The last three Change in Receivables figures came in at -$601000.0 (Q1 2026), -$1.8 million (Q4 2025), and -$191000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | -601,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -601,000.00 |
| Mar 31, 2026 | -601,000.00 |
| Dec 31, 2025 | -1.82 Mn |
| Dec 31, 2025 | -1.82 Mn |
| Sep 30, 2025 | -191,000.00 |
| Sep 30, 2025 | -191,000.00 |
| Jun 30, 2025 | -6.09 Mn |
| Jun 30, 2025 | -6.09 Mn |
| Mar 31, 2025 | 178,000.00 |
| Mar 31, 2025 | 178,000.00 |
| Dec 31, 2024 | -2.23 Mn |
| Dec 31, 2024 | -2.23 Mn |
| Sep 30, 2024 | 3.46 Mn |
| Sep 30, 2024 | 3.46 Mn |
| Jun 30, 2024 | -585,000.00 |
| Jun 30, 2024 | -585,000.00 |
| Mar 31, 2024 | 7.60 Mn |
| Mar 31, 2024 | 7.60 Mn |
| Dec 31, 2023 | 2.92 Mn |
| Dec 31, 2023 | 2.92 Mn |